Stiris Research
Stiris Research is a privately held, founder-owned clinical research organization providing full-service and rescue-focused Phase I–IIIB clinical trial management for biotechnology and pharmaceutical sponsors, with specializations in rare diseases, neurology, and oncology across North America and select global markets.
- Company typePrivate
- Founded2006
- HeadquartersLondon, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Stiris Research does
Stiris Research Inc. is a privately held, founder-owned contract research organization (CRO) founded in 2006 by Shantal Feltham, headquartered in London, Ontario with a US operational base in Cambridge, Massachusetts. The company provides full-service and focused clinical trial management for Phase I through Phase IIIB studies, primarily serving biotechnology and pharmaceutical sponsors with concentrations in rare diseases, neurology/CNS, and oncology. Its core offering is anchored by a proprietary web-based Clinical Trial Management System (CTMS) and validated Electronic Trial Master File (eTMF) that deliver real-time visibility into site status, enrollment, SAE tracking, and regulatory document management, supplemented by a 24/7 EDC help desk and proprietary data visualization tools for discrepancy management.
Stiris differentiates on a "site-first" operating model, with over 70% of its clinical team having prior site-level experience (75% former Clinical Research Coordinators, 60% Registered Nurses) and an explicit commitment to team stability through study lifecycles. Its services span project management, clinical monitoring, medical monitoring, regulatory affairs, biostatistics and data management, study start-up, auditing, and a dedicated Patient Caregiver Liaison (PCL) service for rare and CNS trials. A specialty in trial rescue — over 50 trials rescued and 20+ cited case studies — is a recurring narrative in its go-to-market.
Commercially, Stiris sells directly to biotech and pharmaceutical sponsors through relationship-driven enterprise sales, supplemented by conference presence (BIO, World Orphan Drug Congress, CNS Summit, ALS Drug Development Summit), case studies, and PR. Pricing is quote-based, project-based, and not publicly disclosed, with multi-year contracts ranging from full-service outsourcing to focused functional support. Global reach beyond North America is delivered through a strategic alliance partner network (notably in Asia-Pacific and Latin America) rather than owned offices. Revenue is not publicly disclosed; the firm has historically been recognized on Canadian growth lists (PROFIT 500, PROFIT W100) and is independent, with no disclosed institutional or private equity backing.
Stiris Research firmographics
Firmographics- Name
- Stiris Research
- Legal name
- Stiris Research Inc.
- Website
- https://stirisresearch.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Stiris Research is a privately held, founder-owned clinical research organization providing full-service and rescue-focused Phase I–IIIB clinical trial management for biotechnology and pharmaceutical sponsors, with specializations in rare diseases, neurology, and oncology across North America and select global markets.
- Ownership category
- akta.pro rank
Stiris Research industry classification
Industry- Product category
- Contract Research Organization (CRO) / Clinical Trial Management Services
- NAICS
- Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Management Consulting Services (54161)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Services (8741), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Biostatistics, Statistical Computing & Clinical Programming (SAS/R/Pipelines) (HLACAOAO), Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where Stiris Research is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Stiris Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Trial Management Services: Comprehensive CRO services including project management, clinical monitoring, medical monitoring, regulatory affairs, data management, biostatistics, study start-up, rescue services, and auditing. Revenue generated through project-based contracts for Phase I through Phase IIIB clinical trials.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing tailored to study requirements |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Stiris Research product offering
Product offeringCore offering
Stiris Research is an entrepreneurial Clinical Trial Management CRO providing comprehensive study management solutions for Phase I through Phase IIIB clinical research for biotechnology and pharmaceutical companies. Services are tailor-made from full-service outsourcing to focused clinical trial management, including project management, clinical monitoring, medical monitoring, regulatory affairs, biostatistics and data management, rescue services, auditing, and study start-up. The offering is anchored by a proprietary web-based Clinical Trial Management System (CTMS) and validated Electronic Trial Master File (eTMF) platform.
Product overview
Stiris Research is an entrepreneurial Clinical Research Organization (CRO) providing comprehensive clinical trial management services for Phase I through Phase IIIB studies. The company's offering consists of a unified suite of clinical development services centered around their core Clinical Trial Management System (CTMS/eTMF) technology platform. Their service portfolio includes: Project Management, Clinical Monitoring (CRA services), Medical Monitoring, Rescue Services (for at-risk trials), Biostatistics and Data Management, Regulatory Affairs, Auditing, Study Start Up, and Global Coverage through strategic alliance partners. The company differentiates through a high-engagement model focused on site relationships and patient-centered trial execution, with particular expertise in rare diseases, neurology/neuromuscular disorders, and oncology. Their Patient Caregiver Liaison (PCL) Service provides dedicated support to reduce patient and caregiver burden and improve trial retention.
Differentiator
Problem solved
Functional benefit
Products and services
- Full-Service Clinical Trial Management
- Project Management
Quantifiable outcome
- 100% patient retention when using Patient Caregiver Liaison service; 100% of eligible patients transitioned to open-label extension study
- +4 more outcomes
Companies that use Stiris Research
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Stiris Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Stiris Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Asia-Pacific CRO Alliance PartnercoreStrategic alliance with an Asia-Pacific CRO for global study expansion, enabling Stiris to support trials in Australia-New Zealand region and other global markets beyond North America through seamless collaboration and single point of contact.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Stiris Research competitors and assessment
Company assessmentBroad incumbents
- Parexel: Top-5 global CRO with strong biotech and rare disease franchises. Overlaps Stiris's therapeutic focus but operates at materially larger scale across all phases and geographies.
- Syneos Health: Top-5 CRO with full-service Phase I-IV clinical and commercial services. Competes with Stiris on biotech Phase II-III programs, particularly where sponsors seek a single-vendor solution.
- ICON plc: Top-5 global CRO with full-service Phase I-IV capabilities, including dedicated biotech and rare disease units. Competes with Stiris for biotech sponsors but at materially larger scale and broader service scope.
- IQVIA: Largest global CRO with broad biotech offerings including dedicated rare disease and CNS teams. A direct competitor on enterprise bids where Stiris is too small to compete.
Direct peers
- Medpace: Mid-sized, biotech-focused CRO with full-service Phase I-IV capabilities and a reputation for operational excellence in complex indications. Closely comparable to Stiris in therapeutic specialization and biotech sponsor focus.
- Biorasi: Mid-sized CRO specializing in oncology, rare disease, and CNS — comparable to Stiris in therapeutic focus and mid-sized biotech sponsor orientation.
- MMS Holdings: Mid-sized CRO focused on biostatistics, data management, clinical programming, and regulatory submissions — closely comparable to Stiris's biostatistics/data management service line.
- Premier Research: Mid-sized CRO focused on biotech and specialty pharma with strength in rare disease, neurology, oncology, and pediatrics — directly overlapping Stiris's core therapeutic areas and customer base.
- Worldwide Clinical Trials: Mid-sized global CRO providing full-service Phase I-IV clinical trial management with a strong footprint in biotech, rare disease, and CNS — directly comparable to Stiris's therapeutic focus and mid-sized positioning.
- Rho: Mid-sized CRO with strong biostatistics, data management, and regulatory capabilities supporting biotech and rare disease sponsors — comparable to Stiris on the technical/data services side of the offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Stiris Research social profiles
Digital presenceStiris Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Stiris Research leadership team
Management profileNumber of profiles
Profiles7 records
Stiris Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Stiris Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Stiris Research
What does Stiris Research do?
Stiris Research is an entrepreneurial Clinical Trial Management CRO providing comprehensive study management solutions for Phase I through Phase IIIB clinical research for biotechnology and pharmaceutical companies. Services are tailor-made from full-service outsourcing to focused clinical trial management, including project management, clinical monitoring, medical monitoring, regulatory affairs, biostatistics and data management, rescue services, auditing, and study start-up. The offering is anchored by a proprietary web-based Clinical Trial Management System (CTMS) and validated Electronic Trial Master File (eTMF) platform.
Is Stiris Research a public or private company?
Stiris Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Stiris Research founded?
Stiris Research was founded in 2006. It employs 11 to 50 people.
Where is Stiris Research based?
Stiris Research is headquartered in London, Canada, in the North America region.
How does Stiris Research make money?
One revenue line is on record: clinical Trial Management Services.
Who are Stiris Research's main competitors?
Broad incumbents on record are Parexel, Syneos Health, ICON plc and IQVIA. Direct peers are Medpace, Biorasi, MMS Holdings, Premier Research, Worldwide Clinical Trials and Rho.
Does Stiris Research have an API?
No public API is recorded for Stiris Research.
What industry is Stiris Research in?
Stiris Research's product category is Contract Research Organization (CRO) / Clinical Trial Management Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.